Corporate Board Profile
Tech Score: 40/100
2 mention(s) identify ANNE B. LE GRAND as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| ACCURAY INC | 2021-10-01 | Ms. Le Grand has served as a consultant to IBM Watson Health, a machine intelligence company that is a division of the International Business Machines Corporation (“IBM”), an information technology company, since January 2021. | Ms. Le Grand has served as a consultant and executive at IBM Watson Health, a machine intelligence and information technology company, indicating technical expertise related to software. |
| ACCURAY INC | 2024-10-04 | Ms. Le Grand served as a consultant to IBM Watson Health, a machine intelligence company that is a division of IBM, a publicly traded information technology company, from January 2021 to January 2023. Prior to that, Ms. Le Grand also served as Vice President and General Manager of Imaging, Life Sciences, Oncology and Genomics at IBM Watson Health from July 2019 to December 2020 and VP and General Manager of Imaging at IBM Watson Health from April 2016 to July 2019. | Ms. Le Grand has held senior roles at IBM Watson Health, a machine intelligence company, including VP and General Manager of Imaging, Life Sciences, Oncology and Genomics. She has experience in technology and software-related fields, indicating technical skills relevant to programming. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-10-01 | Ms. Le Grand holds a B.S. in Chemistry from Queens University of Charlotte and has held executive roles at IBM Watson Health and Philips, focusing on healthcare business operations. |
| 2021-10-01 | Ms. Le Grand has served as a consultant to IBM Watson Health, a machine intelligence company that is a division of the International Business Machines Corporation (“IBM”), an information technology company, since January 2021. |
| 2022-09-30 | Anne B. Le Grand has served as a member of our Board since July 2020. Ms. Le Grand has served as a consultant to IBM Watson Health, a machine intelligence company that is a division of the International Business Machines Corporation ("IBM"), a publicly traded information technology company since January 2021. Prior to that, Ms. Le Grand also served as Vice President and General Manager of Imaging, Life Sciences, Oncology and Genomics at IBM Watson Health from July 2019 to December 2020 and VP and General Manager of Imaging at IBM Watson Health from April 2016 to July 2019. Prior to her roles at IBM Watson Health, Ms. Le Grand served as Senior Vice President of Healthcare and General Manager of Therapeutics from January 2015 to April 2016 and Senior Vice President of Healthcare Business Transformation from January 2014 to January 2015 at Philips, a health technology company. Ms. Le Grand previously served in various senior leadership positions at General Electric Healthcare and Eastman Kodak Company and began her career at 3M Company in the Medical Imaging Division. Ms. Le Grand has served as a member of the board of directors of Medimaps Group, SA, a private medical analytics software company, since May 2022. Ms. Le Grand holds a B.S. in Chemistry from Queens University of Charlotte. |
| 2023-09-29 | Ms. Le Grand served as a consultant to IBM Watson Health, a machine intelligence company that is a division of IBM... Ms. Le Grand holds a B.S. in Chemistry from Queens University of Charlotte. |
| 2024-10-04 | Ms. Le Grand served as a consultant to IBM Watson Health, a machine intelligence company that is a division of IBM, a publicly traded information technology company, from January 2021 to January 2023. Prior to that, Ms. Le Grand also served as Vice President and General Manager of Imaging, Life Sciences, Oncology and Genomics at IBM Watson Health from July 2019 to December 2020 and VP and General Manager of Imaging at IBM Watson Health from April 2016 to July 2019. |
Data sourced from SEC filings. Last updated: 2026-02-03